Neurochemical abnormalities and potential changes in α7 nAChRs along with other cholinergic pathways in AD may be associated with cognitive impairment and emphasize the importance of further investigating the receptor’s role in AD. This evidence concerns the gene CHRNA7 and Alzheimer disease.